ERC1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA019513

Antibody HPA019523

Antibody HPA024130

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

The majority of malignant cells showed moderate cytoplasmic and sometimes membranous staining, although most malignancies displayed occasional strongly stained cases e.g. colorectal, testicular, urothelial and skin cancers.A majority of malignant cells displayed moderate to strong cytoplasmic and membranous immunoreactivity. Strongest staining was observed in breast and urothelial cancers. Several malignant lymphomas, melanomas and renal cancers were negative. Most of the malignant cells exhibited weak to moderate cytoplasmic positivity. Occasional cases of testicular cancers showed strong cytoplasmic immunoreactivity. Some cases of gliomas, lymphomas and lung cancers were negative.

Literature conformity

Consistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected